| Replicate Bioscience
replicatebioscience.com
Actively hiring
Immunology & Inflammation Therapeutics
Drug Discovery
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$40M
2 rounds on record
Latest round
$20M
Venture round · Feb 2021 · 5 yr ago
Team
20
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
Backers
1
Apple Tree Partners
The money's age
Long since its last round
67 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 4, 2021
Raised a round Venture round $20M · SEC Form D
Feb 4, 2021
Raised a round Venture round $20M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2021 | $20M | — | SEC Form D |
| Venture round | Feb 2021 | $20M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Replicate Bioscience, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Michael EhlersExecutive Officer, DirectorSEC Form D
Nathaniel WangExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Apple Tree Partners Similar startupsby what they do, their industry and backers
AltruBio. Developing safer, more durable treatments to improve the lives of patients.
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
VISION： Eliminating R&D bottlenecks for novel value for patients Mission： We will form a selected few and self-organized pharma…
Ring Therapeutics is a biotechnology company creating novel vector conjugate medicines that carry more and reach further, expanding…
News
San Diego based Replicate Bioscience believes that self-replicating RNA has key advantages
Read more
Report
Replicate Bioscience Awarded Grant to Advance srRNA Vaccine Candidates for Tuberculosis
Company receives grant from the Gates Foundation to develop srRNA vaccine candidates for tuberculosis, subject to humanitarian licensing terms SAN DIEGO, June 19, 2026 /PRNewswire/ - Replicate Bioscience, a clinical-stage company pioneering novel self-rep
Read more
Report
Report
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Michael Ehlers
Executive Officer, Director
Nathaniel Wang
Executive Officer, Director
Seth Harrison
Director
Joseph Yanchik
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ
50-200 est. staff